Viewing Study NCT05740995


Ignite Creation Date: 2025-12-24 @ 1:48 PM
Ignite Modification Date: 2025-12-30 @ 7:25 AM
Study NCT ID: NCT05740995
Status: RECRUITING
Last Update Posted: 2023-03-21
First Post: 2023-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module